| Dr Yayra Musabek, MD | |
|
455 Toll Gate Rd, Warwick, RI 02886-2759 | |
| (401) 737-7000 | |
| Not Available |
| Full Name | Dr Yayra Musabek |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 18 Years |
| Location | 455 Toll Gate Rd, Warwick, Rhode Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750677969 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | MD14652 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kent County Memorial Hospital | Warwick, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Affinity Physicians Llc. | 0244413391 | 619 |
News Archive
The latest NHS quarterly financial performance report, published today (Tuesday 20 February, 2007) shows that almost a third of England's hospital trusts, and almost half its Primary Care Trusts, are forecast to be in deficit at the end of this financial year.
Agenus Inc. announced today that the company received a letter from the Listing Qualifications Staff of The NASDAQ Stock Market LLC on March 3, 2011 indicating that the company is not in compliance with Nasdaq Marketplace Rule 5550(a)(2) (the "Bid Price Requirement") because the bid price for the company's common stock has closed below the minimum $1.00 per share requirement for 30 consecutive business days.
Romark Laboratories announced results from its STEALTH C-3 clinical trial, a phase 2 clinical study of nitazoxanide in treatment-naive patients with genotype 1 chronic hepatitis C. Study results were presented as a late breaking communication at the International Liver Congress™ 2010, the 45th Annual Meeting of the European Association for the Study of the Liver in Vienna, Austria.
The Walter Reed Army Institute of Research this week administered the first vaccine in a Phase 1 clinical trial to evaluate the safety and immunogenicity of a Marburg vaccine candidate in healthy adult volunteers.
Doctors can be taught to listen better to individual circumstances that may affect patient care, according to researchers at the University of Illinois at Chicago College of Medicine. The findings are reported in the Sept. 15 issue of JAMA.
› Verified 2 days ago
| Entity Name | Affinity Physicians Llc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184944662 PECOS PAC ID: 0244413391 Enrollment ID: O20110326000053 |
News Archive
The latest NHS quarterly financial performance report, published today (Tuesday 20 February, 2007) shows that almost a third of England's hospital trusts, and almost half its Primary Care Trusts, are forecast to be in deficit at the end of this financial year.
Agenus Inc. announced today that the company received a letter from the Listing Qualifications Staff of The NASDAQ Stock Market LLC on March 3, 2011 indicating that the company is not in compliance with Nasdaq Marketplace Rule 5550(a)(2) (the "Bid Price Requirement") because the bid price for the company's common stock has closed below the minimum $1.00 per share requirement for 30 consecutive business days.
Romark Laboratories announced results from its STEALTH C-3 clinical trial, a phase 2 clinical study of nitazoxanide in treatment-naive patients with genotype 1 chronic hepatitis C. Study results were presented as a late breaking communication at the International Liver Congress™ 2010, the 45th Annual Meeting of the European Association for the Study of the Liver in Vienna, Austria.
The Walter Reed Army Institute of Research this week administered the first vaccine in a Phase 1 clinical trial to evaluate the safety and immunogenicity of a Marburg vaccine candidate in healthy adult volunteers.
Doctors can be taught to listen better to individual circumstances that may affect patient care, according to researchers at the University of Illinois at Chicago College of Medicine. The findings are reported in the Sept. 15 issue of JAMA.
› Verified 2 days ago
| Entity Name | Blueprint Healthcare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467927483 PECOS PAC ID: 1153665062 Enrollment ID: O20200626000337 |
News Archive
The latest NHS quarterly financial performance report, published today (Tuesday 20 February, 2007) shows that almost a third of England's hospital trusts, and almost half its Primary Care Trusts, are forecast to be in deficit at the end of this financial year.
Agenus Inc. announced today that the company received a letter from the Listing Qualifications Staff of The NASDAQ Stock Market LLC on March 3, 2011 indicating that the company is not in compliance with Nasdaq Marketplace Rule 5550(a)(2) (the "Bid Price Requirement") because the bid price for the company's common stock has closed below the minimum $1.00 per share requirement for 30 consecutive business days.
Romark Laboratories announced results from its STEALTH C-3 clinical trial, a phase 2 clinical study of nitazoxanide in treatment-naive patients with genotype 1 chronic hepatitis C. Study results were presented as a late breaking communication at the International Liver Congress™ 2010, the 45th Annual Meeting of the European Association for the Study of the Liver in Vienna, Austria.
The Walter Reed Army Institute of Research this week administered the first vaccine in a Phase 1 clinical trial to evaluate the safety and immunogenicity of a Marburg vaccine candidate in healthy adult volunteers.
Doctors can be taught to listen better to individual circumstances that may affect patient care, according to researchers at the University of Illinois at Chicago College of Medicine. The findings are reported in the Sept. 15 issue of JAMA.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yayra Musabek, MD 455 Toll Gate Rd, Warwick, RI 02886-2759 Ph: (401) 737-7000 | Dr Yayra Musabek, MD 455 Toll Gate Rd, Warwick, RI 02886-2759 Ph: (401) 737-7000 |
News Archive
The latest NHS quarterly financial performance report, published today (Tuesday 20 February, 2007) shows that almost a third of England's hospital trusts, and almost half its Primary Care Trusts, are forecast to be in deficit at the end of this financial year.
Agenus Inc. announced today that the company received a letter from the Listing Qualifications Staff of The NASDAQ Stock Market LLC on March 3, 2011 indicating that the company is not in compliance with Nasdaq Marketplace Rule 5550(a)(2) (the "Bid Price Requirement") because the bid price for the company's common stock has closed below the minimum $1.00 per share requirement for 30 consecutive business days.
Romark Laboratories announced results from its STEALTH C-3 clinical trial, a phase 2 clinical study of nitazoxanide in treatment-naive patients with genotype 1 chronic hepatitis C. Study results were presented as a late breaking communication at the International Liver Congress™ 2010, the 45th Annual Meeting of the European Association for the Study of the Liver in Vienna, Austria.
The Walter Reed Army Institute of Research this week administered the first vaccine in a Phase 1 clinical trial to evaluate the safety and immunogenicity of a Marburg vaccine candidate in healthy adult volunteers.
Doctors can be taught to listen better to individual circumstances that may affect patient care, according to researchers at the University of Illinois at Chicago College of Medicine. The findings are reported in the Sept. 15 issue of JAMA.
› Verified 2 days ago
Dr. Eric Mastrogiacomo, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7010 Fax: 401-736-4546 | |
Sajedabanu Momin, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 260-443-4295 | |
Dr. Paul Francis Mckenney, M.D. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 33 Beach Park Ave, Warwick, RI 02886 Phone: 401-739-6929 | |
Dr. Manoj Gurung, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Kent Hospital, Warwick, RI 02886 Phone: 401-737-7000 | |
Denise M Arcand, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7010 Fax: 401-736-4546 | |
Shereen A. Santee, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7010 Fax: 401-736-4546 |